But we know there are therapeutics to help lessen the severity and at this point, it’s pretty safe to say they’re just as effective as the vaxxes, if not more so. Those “rare” breakthrough cases, some with deaths, are well into the tens of thousands.
Yes! Merck is supposedly conducting a trial on a therapeutic as we speak! You know the one called molnupiravir. This little project set our fed govt back 1.7 B to develop.
Funny, their course of treatment for this experimental therapy is every 12 hours for 5 days. The duration of administration for their research protocol is somewhat similar to what the good clinicians at FLCCC.net are recommending for Ivermectin for the early outpatient protocol.